as of 02-23-2026 3:54pm EST
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | MISSISSAUGA |
| Market Cap: | 230.4M | IPO Year: | 2017 |
| Target Price: | $12.00 | AVG Volume (30 days): | 148.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.14 | EPS Growth: | -16.42 |
| 52 Week Low/High: | $3.90 - $8.95 | Next Earning Date: | 01-01-0001 |
| Revenue: | $10,680,000 | Revenue Growth: | 48.35% |
| Revenue Growth (this year): | 61.09% | Revenue Growth (next year): | 120.94% |
| P/E Ratio: | 6.18 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
See how PROF stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PROF Profound Medical Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.